Chargement en cours...
Hypothalamic CaMKKβ mediates glucagon anorectic effect and its diet-induced resistance
OBJECTIVE: Glucagon receptor antagonists and humanized glucagon antibodies are currently studied as promising therapies for obesity and type II diabetes. Among its variety of actions, glucagon reduces food intake, but the molecular mechanisms mediating this effect as well as glucagon resistance are...
Enregistré dans:
| Publié dans: | Mol Metab |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4731730/ https://ncbi.nlm.nih.gov/pubmed/26909312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2015.09.014 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|